Publications by authors named "Nita L Seibel"

73Publications

Precision Medicine in Pediatric Oncology.

Surg Oncol Clin N Am 2020 Jan 29;29(1):63-72. Epub 2019 Oct 29.

Division of Cancer Treatment and Diagnosis, Clinical Investigations Branch, National Cancer Institute, 9609 Medical Center Drive, 5W340, MSC9737, Bethesda, MD 20892, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soc.2019.08.005DOI Listing
January 2020

Influences Antimetabolite Drug Sensitivity and Prognosis of Acute Lymphoblastic Leukemia.

Clin Cancer Res 2020 01 1;26(1):256-264. Epub 2019 Oct 1.

Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-0190DOI Listing
January 2020

National Cancer Institute Basket/Umbrella Clinical Trials: MATCH, LungMAP, and Beyond.

Cancer J 2019 Jul/Aug;25(4):272-281

Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000389DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658131PMC
July 2020

Reply to D.M. Green.

J Clin Oncol 2018 Sep 13:JCO1800659. Epub 2018 Sep 13.

David B. Dix, British Columbia Children's Hospital, Vancouver, BC, Canada; Nita L. Seibel, National Cancer Institute, Bethesda, MD; Yueh-Yun Chi, University of Florida, Gainesville, FL; Geetika Khanna, Washington University School of Medicine, St Louis, MO; Elizabeth A. Mullen, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA; James I. Geller, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; John A. Kalapurakal, Lurie Comprehensive Cancer Centre of Northwestern University, Chicago, IL; Peter F. Ehrlich, University of Michigan, Ann Arbor, MI; Marcio H. Malogolowkin, University of California at Davis Comprehensive Cancer Center, Sacramento, CA; Conrad V. Fernandez, IWK Health Center, Dalhousie University, Halifax, NS, Canada; and Jeffrey S. Dome, Children's National Health System, George Washington University School of Medicine and Health Sciences, Washington, DC.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.18.00659
Publisher Site
http://dx.doi.org/10.1200/JCO.18.00659DOI Listing
September 2018

Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study.

J Clin Oncol 2018 06 16;36(16):1564-1570. Epub 2018 Apr 16.

David B. Dix, British Columbia Children's Hospital, Vancouver, British Columbia; Paul E. Grundy, University of Alberta, Edmonton, Alberta; Conrad V. Fernandez, Dalhousie University, Halifax, Nova Scotia, Canada; Nita L. Seibel, National Cancer Institute, Bethesda, MD; Yueh-Yun Chi, University of Florida, Gainesville, FL; Geetika Khanna, Washington University School of Medicine, St Louis, MO; Eric Gratias, University of Tennessee College of Medicine Chattanooga, Chattanooga, TN; James R. Anderson, Merck Research Laboratories, North Wales, PA; Elizabeth A. Mullen, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA; James I. Geller, Cincinnati Children's Hospital Medical Center, Cincinnati; Julie M. Gastier-Foster and Elizabeth Wagner, Nationwide Children's Hospital; Julie M. Gastier-Foster, The Ohio State University College of Medicine, Columbus, OH; John A. Kalapurakal, Lurie Comprehensive Cancer Centre of Northwestern University; Elizabeth J. Perlman, Ann and Robert H. Lurie Children's Hospital, Chicago, IL; Arnold C. Paulino, MD Anderson Cancer Center, Houston, TX; Peter F. Ehrlich, University of Michigan, Ann Arbor, MI; Marcio Malogolowkin, University of California at Davis Comprehensive Cancer Center, Sacramento, CA; Jeffrey S. Dome, George Washington University School of Medicine and Health Sciences, Washington, DC; on behalf of the AREN0533 Study Committee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.1931DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075846PMC
June 2018

Efficacy of micafungin for the treatment of invasive candidiasis and candidaemia in patients with neutropenia.

Mycoses 2018 May 2;61(5):331-336. Epub 2018 Feb 2.

Charité University Medicine, Humboldt University, Berlin, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/myc.12748
Publisher Site
http://dx.doi.org/10.1111/myc.12748DOI Listing
May 2018

Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.

J Clin Oncol 2017 Aug 4;35(22):2580-2587. Epub 2017 May 4.

Julie R. Park, Seattle Children's Hospital and University of Washington School of Medicine, Seattle, WA; Rochelle Bagatell and John M. Maris, Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA; Susan L. Cohn, University of Chicago, Chicago, IL; Andrew D. Pearson, Institute of Cancer Research and Royal Marsden National Health Service (NHS) Foundation Trust, Sutton, Surrey; Susan Burchill, Leeds Institute of Cancer and Pathology, St James University Hospital, Leeds; Kieran McHugh and Penelope Brock, Great Ormond Street Hospital for Children, NHS Trust, London, United Kingdom; Judith G. Villablanca, Children's Hospital Los Angeles and University of Southern California Keck School of Medicine, Los Angeles; Katherine K. Matthay, University of California San Francisco School of Medicine, San Francisco, CA; Frank Berthold, Children's Hospital and University of Cologne, Köln, Germany; Ariane Boubaker, Institute of Radiology, Clinique de La Source, Lausanne, Switzerland; Jed G. Nuchtern, Texas Children's Hospital and Baylor College of Medicine, Houston, TX; Wendy B. London, Dana-Farber/Boston Children's Cancer and Blood Disorder Center, Harvard Medical School, Boston, MA; Nita L. Seibel and O. Wolf Lindwasser, National Cancer Institute, Bethesda, MD; Gudrun Schleiermacher, Institut Curie, Paris; Dominique Valteau-Couanet, Gustave Roussy, Villejuif, France; and Ruth Ladenstein, Children's Cancer Research Institute, St Anna Children's Hospital, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.72.0177DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676955PMC
August 2017

Pediatric oncology enters an era of precision medicine.

Curr Probl Cancer 2017 May - Jun;41(3):194-200. Epub 2017 Feb 1.

Department of Pediatrics, Baylor College of Medicine, Houston, Texas; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.currproblcancer.2017.01.002DOI Listing
March 2018

Safety, Tolerability, and Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Pediatric Patients.

Antimicrob Agents Chemother 2017 02 24;61(2). Epub 2017 Jan 24.

Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.01477-16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278758PMC
February 2017

Population Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Children.

Antimicrob Agents Chemother 2016 12 21;60(12):7340-7346. Epub 2016 Nov 21.

Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.01427-16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119015PMC
December 2016

Low Enrollment of Adolescents and Young Adults Onto Cancer Trials: Insights From the Community Clinical Oncology Program.

J Oncol Pract 2016 Apr 29;12(4):e388-95. Epub 2016 Mar 29.

Albert Einstein College of Medicine, Bronx, NY; National Cancer Institute, Bethesda, MD; Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, MI; University of Texas Health Science Center at San Antonio, San Antonio, TX; University of California, Davis; and University of Southern California, Los Angeles, CA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2015.009084DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960459PMC
April 2016

Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children's Oncology Group.

J Immunother 2015 Sep;38(7):299-305

*Department of Pediatric Hematology-Oncology, Children's National Medical Center, George Washington University School of Medicine and Public Health, Washington, DC †Clinical Investigations Branch, Cancer Therapy Evaluation Program, NCI, Bethesda ¶¶Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD ‡Keck School of Medicine, University of Southern California ¶Division of Hematology-Oncology, Children's Hospital Los Angeles, Los Angeles §Children's Oncology Group, Arcadia ‡‡Department of Pediatrics, City of Hope National Medical Center, Duarte, CA ∥Department of Biostatistics and Bioinformatics, Emory University ∥∥Aflac Cancer and Blood Disorder Center, Children's Healthcare of Atlanta/Emory University, Atlanta, GA #Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN **Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA ††Pediatric Hematology-Oncology, C.S. Mott Children's Hospital, Ann Arbor, MI §§Division of Pediatrics, Children's Cancer Hospital at the University of Texas M.D. Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000088DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536569PMC
September 2015

Psychosocial and Neurocognitive Outcomes in Adult Survivors of Adolescent and Early Young Adult Cancer: A Report From the Childhood Cancer Survivor Study.

J Clin Oncol 2015 Aug 6;33(23):2545-52. Epub 2015 Jul 6.

Pinki K. Prasad, Louisiana State University School of Medicine, New Orleans, LA; Kristina K. Hardy, Children's National Medical Center, Washington, DC; Nan Zhang, Deokumar Srivastava, Gregory T. Armstrong, Leslie L. Robison, and Kevin Krull, St Jude Children's Research Hospital, Memphis, TN; Lonnie Zeltzer, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA; Marilyn Stovall, The University of Texas MD Anderson Cancer Center, Houston, TX; Nita L. Seibel, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD; Wendy Leisenring, Fred Hutchinson Cancer Research Center, Seattle, WA; and Kim Edelstein, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525049PMC
http://dx.doi.org/10.1200/JCO.2014.57.7528DOI Listing
August 2015

Are we missing an opportunity for cancer prevention? Human papillomavirus vaccination for survivors of pediatric and young adult cancers.

Cancer 2015 Oct 25;121(19):3395-402. Epub 2015 Jun 25.

Clinical Investigations Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29515DOI Listing
October 2015

US trends in survival disparities among adolescents and young adults with non-Hodgkin lymphoma.

Cancer Causes Control 2015 Aug 18;26(8):1153-62. Epub 2015 Jun 18.

Outcomes Research Branch, Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, 9609 Medical Center Drive, Rockville, MD, 20850, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-015-0609-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556271PMC
August 2015

The Clinical Trials Gap for Adolescents and Young Adults with Cancer: Recent Progress and Conceptual Framework for Continued Research.

Curr Pediatr Rep 2015 Jun 18;3(2):137-145. Epub 2015 Feb 18.

Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s40124-015-0075-y
Publisher Site
http://dx.doi.org/10.1007/s40124-015-0075-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319956PMC
June 2015

Identifying and addressing the needs of adolescents and young adults with cancer: summary of an Institute of Medicine workshop.

Oncologist 2015 Feb 7;20(2):186-95. Epub 2015 Jan 7.

Institute of Medicine, Washington, D.C., USA; Roswell Park Cancer Institute, Buffalo, New York, USA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, USA; Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts, USA: School of Medicine & Public Health, University of California, Los Angeles, Los Angeles, California, USA; Oregon Health & Science University Knight Cancer Institute, Portland, Oregon, USA; St. Jude Children's Research Hospital, Memphis, Tennessee, USA; Oncology Nursing Society, Pittsburgh, Pennsylvania, USA; Memorial Sloan-Kettering Cancer Center, New York, New York, USA; LIVESTRONG Foundation, Austin, Texas, USA; Centers for Disease Control and Prevention, Atlanta, Georgia, USA; National Cancer Institute, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0265DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319626PMC
February 2015

Adolescent and young adult cancer survival.

J Natl Cancer Inst Monogr 2014 Nov;2014(49):228-35

Division of Cancer Control and Population Sciences (DRL, AWS, MRS), Division of Cancer Treatment and Diagnosis (NLS), National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
https://academic.oup.com/jncimono/article-lookup/doi/10.1093
Publisher Site
http://dx.doi.org/10.1093/jncimonographs/lgu019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841167PMC
November 2014

Use of appropriate initial treatment among adolescents and young adults with cancer.

J Natl Cancer Inst 2014 Nov 9;106(11). Epub 2014 Oct 9.

Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC (ALP); Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD (LCH); Cook Children's Medical Center and University of North Texas Health Science Center Fort Worth, TX (KA); Public Health Institute/Cancer Registry of Greater California, Sacramento, CA (RDC); Monroe Carell Jr. Children's Hospital, Vanderbilt-Ingram Cancer Center, Nashville, TN (DLF); Keck School of Medicine, University of Southern California, Los Angeles, CA (ASH); Departments of Oncology and Pathology, Wayne State University, Detroit, MI (IK); Cancer Prevention Institute of California, Fremont, CA (THMK); School of Medicine, Stanford University, Stanford, CA (THMK); Information Management Services, Inc., Silver Spring, MD (GK); Epidemiology Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA (SMS); Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD (NLS); Department of Urology, Division of Pediatric Urology, University of Washington, Seattle Children's Hospital, Seattle, WA (MS); Department of Epidemiology, University of Iowa, Iowa City, IA (MMW); Louisiana State University, New Orleans, LA (XCW).

View Article

Download full-text PDF

Source
https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnc
Publisher Site
http://dx.doi.org/10.1093/jnci/dju300DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200030PMC
November 2014

Declining childhood and adolescent cancer mortality.

Cancer 2014 Aug 22;120(16):2497-506. Epub 2014 May 22.

Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28748DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136455PMC
August 2014

Impact on survival and toxicity by duration of weight extremes during treatment for pediatric acute lymphoblastic leukemia: A report from the Children's Oncology Group.

J Clin Oncol 2014 May 31;32(13):1331-7. Epub 2014 Mar 31.

Etan Orgel, Jonathan Jaques Children's Cancer Center, Miller Children's Hospital, Long Beach; Etan Orgel, Paul S. Gaynon, and David R. Freyer, Keck School of Medicine, University of Southern California; Etan Orgel, Richard Sposto, Jemily Malvar, Paul S. Gaynon, and David R. Freyer, Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles; Richard Sposto, University of Southern California, Los Angeles, CA; Nita L. Seibel, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD; and Elena Ladas, Center for Comprehensive Wellness, Columbia University, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.52.6962DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992723PMC
May 2014

Outcomes of patients with revised stage I clear cell sarcoma of kidney treated in National Wilms Tumor Studies 1-5.

Int J Radiat Oncol Biol Phys 2013 Feb 1;85(2):428-31. Epub 2012 Jun 1.

Northwestern University, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2012.04.023DOI Listing
February 2013

Bilateral synchronous tibial periosteal osteosarcoma with familial incidence.

Skeletal Radiol 2012 Aug 17;41(8):1005-9. Epub 2012 Feb 17.

Department of Orthopaedics, SUNY Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, NY 11203, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00256-012-1376-7DOI Listing
August 2012

Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children's Oncology Group.

Cancer 2012 Sep 17;118(18):4597-605. Epub 2012 Jan 17.

Department of Pediatric Hematology-Oncology, Dana-Farber/Children's Hospital Cancer Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27414DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008337PMC
September 2012

Survival after relapse in childhood acute lymphoblastic leukemia.

Authors:
Nita L Seibel

Clin Adv Hematol Oncol 2011 Jun;9(6):476-8

Pediatric Solid Tumor Therapeutics, Clinical Investigations Branch, Cancer Therapy Evaluation Program, The National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
June 2011

Dactinomycin and vincristine toxicity in the treatment of childhood cancer: a retrospective study from the Children's Oncology Group.

Pediatr Blood Cancer 2011 Aug 1;57(2):252-7. Epub 2010 Dec 1.

Children's Oncology Group and Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.22882DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467305PMC
August 2011

Unique characteristics of adolescent and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer.

J Natl Cancer Inst 2011 Apr 24;103(8):628-35. Epub 2011 Mar 24.

Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, 6130 Executive Blvd, Executive Plaza North, Rockville, MD 20852, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djr094DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079851PMC
April 2011

Expanded Access Through Cancer Trials Support Unit to Children's Oncology Group Sarcoma Trial AEWS1031 for Adolescents and Young Adults.

J Adolesc Young Adult Oncol 2011 Mar;1(1):61-3

3 Cancer Therapy Evaluation Program, Clinical Investigations Branch, National Cancer Institute , Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/jayao.2011.1502DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976716PMC
March 2011

Aprepitant use in children, adolescents, and young adults for the control of chemotherapy-induced nausea and vomiting (CINV).

J Pediatr Hematol Oncol 2010 Oct;32(7):e268-71

Division of Hematology and Oncology, Children's National Medical Center, Washington, DC, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00043426-201010000-000
Publisher Site
http://dx.doi.org/10.1097/MPH.0b013e3181e5e1afDOI Listing
October 2010

Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study.

Pediatr Blood Cancer 2010 Sep;55(3):421-9

Therapeutic Advances in Childhood Leukemia Consortium, USC-CHLA Institute for Pediatric Clinical Research, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.22612DOI Listing
September 2010

Outcomes for children and adolescents with cancer: challenges for the twenty-first century.

J Clin Oncol 2010 May 19;28(15):2625-34. Epub 2010 Apr 19.

Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.27.0421DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881732PMC
May 2010

Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study.

J Clin Oncol 2010 Feb 19;28(4):648-54. Epub 2009 Oct 19.

Therapeutic Advances in Childhood Leukemia Consortium, Institute for Pediatric Clinical Research and Childrens Center for Cancer and Blood Diseases, University of Southern California-Childrens Hospital Los Angeles, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.22.2950DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815999PMC
February 2010

Weight patterns in children with higher risk ALL: A report from the Children's Oncology Group (COG) for CCG 1961.

Pediatr Blood Cancer 2009 Dec;53(7):1249-54

Children's Cancer and Blood Disorder Center, South Carolina Cancer Center, Columbia, South Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.22237DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044478PMC
December 2009

Treatment of acute lymphoblastic leukemia in children and adolescents: peaks and pitfalls.

Authors:
Nita L Seibel

Hematology Am Soc Hematol Educ Program 2008 :374-80

Clinical Investigations Branch, Cancer Treatment Evaluation Program, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2008.1.374DOI Listing
July 2009

Acute lymphoblastic leukemia: an historical perspective.

Authors:
Nita L Seibel

Hematology Am Soc Hematol Educ Program 2008 :365

View Article

Download full-text PDF

Source
http://www.asheducationbook.org/cgi/doi/10.1182/asheducation
Publisher Site
http://dx.doi.org/10.1182/asheducation-2008.1.365DOI Listing
July 2009

Phase 2 study of docetaxel in the treatment of childhood refractory acute leukemias: a Children's Oncology Group report.

Pediatr Blood Cancer 2008 Mar;50(3):533-6

Childrens Hospital Los Angeles, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.21313DOI Listing
March 2008

Obesity and outcome in pediatric acute lymphoblastic leukemia.

J Clin Oncol 2007 May;25(15):2063-9

Childrens Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, CA 90027, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.07.7792DOI Listing
May 2007

Concomitant Candida epiglottitis and disseminated Varicella zoster virus infection associated with acute lymphoblastic leukemia.

J Pediatr Hematol Oncol 2006 Nov;28(11):757-9

Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00043426-200611000-000
Publisher Site
http://dx.doi.org/10.1097/01.mph.0000243654.18314.c1DOI Listing
November 2006

Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents.

Antimicrob Agents Chemother 2005 Nov;49(11):4536-45

Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bldg. 10-CRC, Room 1W-5750, 10 Center Drive, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.49.11.4536-4545.2005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1280172PMC
November 2005

Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients.

Antimicrob Agents Chemother 2005 Aug;49(8):3317-24

Pediatric Oncology Branch, National Cancer Institute, Bldg. 10, Rm. 13N-240, 10 Center Drive, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.49.8.3317-3324.2005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1196271PMC
August 2005

Primary cutaneous CD30-positive anaplastic large cell lymphoma in childhood: report of 4 cases and review of the literature.

Pediatr Dev Pathol 2005 Jan-Feb;8(1):52-60. Epub 2005 Feb 23.

Department of Anatomic Pathology, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10024-004-8087-6DOI Listing
June 2005

Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections.

Pediatr Infect Dis J 2005 Feb;24(2):167-74

Department of Pediatrics, Division of Hematology/Oncology, Sinai Hospital of Baltimore, Baltimore, MD 21215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.inf.0000153183.51258.b8DOI Listing
February 2005

Changes of amino acid serum levels in pediatric patients with higher-risk acute lymphoblastic leukemia (CCG-1961).

In Vivo 2004 Mar-Apr;18(2):107-12

Childrens Hospital Los Angeles, Los Angeles, CA 90027, USA.

View Article

Download full-text PDF

Source
November 2004

Successful treatment of invasive aspergillosis in two patients with acute myelogenous leukemia.

J Pediatr Hematol Oncol 2003 Mar;25(3):252-6

Department of Pediatic Hematology/Oncology, Children's natonal Medical Center, Washington, DC 20010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00043426-200303000-00014DOI Listing
March 2003